hVIVO PLC
LSE:HVO

Watchlist Manager
hVIVO PLC Logo
hVIVO PLC
LSE:HVO
Watchlist
Price: 27.3 GBX -0.18% Market Closed
Market Cap: 185.7m GBX
Have any thoughts about
hVIVO PLC?
Write Note

Intrinsic Value

The intrinsic value of one HVO stock under the Base Case scenario is 26.6 GBX. Compared to the current market price of 27.3 GBX, hVIVO PLC is Overvalued by 3%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

HVO Intrinsic Value
26.6 GBX
Overvaluation 3%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
hVIVO PLC

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for HVO cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about HVO?
Bearish
Neutral
Bullish
Discover Undervalued Stocks
Life Sciences Tools & Services Industry

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about hVIVO PLC

Provide an overview of the primary business activities
of hVIVO PLC.

What unique competitive advantages
does hVIVO PLC hold over its rivals?

What risks and challenges
does hVIVO PLC face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for hVIVO PLC.

Provide P/S
for hVIVO PLC.

Provide P/E
for hVIVO PLC.

Provide P/OCF
for hVIVO PLC.

Provide P/FCFE
for hVIVO PLC.

Provide P/B
for hVIVO PLC.

Provide EV/S
for hVIVO PLC.

Provide EV/GP
for hVIVO PLC.

Provide EV/EBITDA
for hVIVO PLC.

Provide EV/EBIT
for hVIVO PLC.

Provide EV/OCF
for hVIVO PLC.

Provide EV/FCFF
for hVIVO PLC.

Provide EV/IC
for hVIVO PLC.

Show me price targets
for hVIVO PLC made by professional analysts.

What are the Revenue projections
for hVIVO PLC?

How accurate were the past Revenue estimates
for hVIVO PLC?

What are the Net Income projections
for hVIVO PLC?

How accurate were the past Net Income estimates
for hVIVO PLC?

What are the EPS projections
for hVIVO PLC?

How accurate were the past EPS estimates
for hVIVO PLC?

What are the EBIT projections
for hVIVO PLC?

How accurate were the past EBIT estimates
for hVIVO PLC?

Compare the revenue forecasts
for hVIVO PLC with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of hVIVO PLC and its key competitors using the latest financial data.

Compare historical revenue growth rates
of hVIVO PLC against its competitors.

Analyze the profit margins
(gross, operating, and net) of hVIVO PLC compared to its peers.

Compare the P/E ratios
of hVIVO PLC against its peers.

Discuss the investment returns and shareholder value creation
comparing hVIVO PLC with its peers.

Analyze the financial leverage
of hVIVO PLC compared to its main competitors.

Show all profitability ratios
for hVIVO PLC.

Provide ROE
for hVIVO PLC.

Provide ROA
for hVIVO PLC.

Provide ROIC
for hVIVO PLC.

Provide ROCE
for hVIVO PLC.

Provide Gross Margin
for hVIVO PLC.

Provide Operating Margin
for hVIVO PLC.

Provide Net Margin
for hVIVO PLC.

Provide FCF Margin
for hVIVO PLC.

Show all solvency ratios
for hVIVO PLC.

Provide D/E Ratio
for hVIVO PLC.

Provide D/A Ratio
for hVIVO PLC.

Provide Interest Coverage Ratio
for hVIVO PLC.

Provide Altman Z-Score Ratio
for hVIVO PLC.

Provide Quick Ratio
for hVIVO PLC.

Provide Current Ratio
for hVIVO PLC.

Provide Cash Ratio
for hVIVO PLC.

What is the historical Revenue growth
over the last 5 years for hVIVO PLC?

What is the historical Net Income growth
over the last 5 years for hVIVO PLC?

What is the current Free Cash Flow
of hVIVO PLC?

Discuss the annual earnings per share (EPS)
trend over the past five years for hVIVO PLC.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
hVIVO PLC

Current Assets 57.8m
Cash & Short-Term Investments 37.1m
Receivables 20.4m
Other Current Assets 340k
Non-Current Assets 29.9m
PP&E 20.2m
Intangibles 5.7m
Other Non-Current Assets 4m
Current Liabilities 36m
Accounts Payable 34.1m
Other Current Liabilities 1.9m
Non-Current Liabilities 13.3m
Long-Term Debt 11.7m
Other Non-Current Liabilities 1.6m
Efficiency

Earnings Waterfall
hVIVO PLC

Revenue
64.4m GBP
Operating Expenses
-51m GBP
Operating Income
13.3m GBP
Other Expenses
4.1m GBP
Net Income
17.4m GBP

Free Cash Flow Analysis
hVIVO PLC

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

HVO Profitability Score
Profitability Due Diligence

hVIVO PLC's profitability score is 73/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROIC
Exceptional ROE
Exceptional ROIC
Positive Free Cash Flow
73/100
Profitability
Score

hVIVO PLC's profitability score is 73/100. The higher the profitability score, the more profitable the company is.

HVO Solvency Score
Solvency Due Diligence

hVIVO PLC's solvency score is 68/100. The higher the solvency score, the more solvent the company is.

Negative Net Debt
High Altman Z-Score
Low D/E
Long-Term Solvency
68/100
Solvency
Score

hVIVO PLC's solvency score is 68/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

HVO Price Targets Summary
hVIVO PLC

Wall Street analysts forecast HVO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for HVO is 38.59 GBX with a low forecast of 35.35 GBX and a high forecast of 44.1 GBX.

Lowest
Price Target
35.35 GBX
29% Upside
Average
Price Target
38.59 GBX
41% Upside
Highest
Price Target
44.1 GBX
62% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for HVO?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for HVO is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

hVIVO PLC Logo
hVIVO PLC

Country

United Kingdom

Industry

Life Sciences Tools & Services

Market Cap

184.4m GBP

Dividend Yield

0.73%

Description

hVIVO PLC provides pharmaceutical development services. The firm is engaged in testing infectious and respiratory disease vaccines and therapeutics using human challenge clinical trials. The company provides end-to-end early clinical development services to its client base, which includes global biopharma companies. The company offers a portfolio of approximately 10+ human challenge models to test a range of infectious and respiratory disease products, challenge agent manufacturing, specialist drug development, and clinical consultancy services via its Venn Life Sciences brand, and a lab offering via its hLAB brand, which includes virology, immunology biomarker and molecular testing. The company offers additional clinical field trial services, such as patient recruitment and clinical trial site services. The company runs challenge studies in from its Whitechapel quarantine clinic, and its QMB clinic with its specialized on-site virology and immunology laboratory.

Contact

London
Queen Mary BioEnterprises Innovation Centre, 42 New Road
+442890737900
hvivo.com

IPO

2012-12-14

Employees

235

Officers

CEO & Director
Dr. Yamin Mohammed Khan Ph.D.
CFO & Executive Director
Mr. Stephen Pinkerton
Chief Scientific Officer
Mr. Andrew Catchpole
Head of QA
Ms. Teja Marathe-Sarvadikar

See Also

Discover More
What is the Intrinsic Value of one HVO stock?

The intrinsic value of one HVO stock under the Base Case scenario is 26.6 GBX.

Is HVO stock undervalued or overvalued?

Compared to the current market price of 27.3 GBX, hVIVO PLC is Overvalued by 3%.

Back to Top